
Proventa International is a management consultancy that specialises in business development services helping companies worldwide. #ProventaSM
London
Joined November 2014
- Tweets3.6K
- Following726
- Followers931
- Likes500
Proventa International retweeted
[TUESDAY, MAY 10 -- SAN FRANCISCO] Join us in San Francisco, along with a host of drug discovery professionals from across the West Coast, to discover new insights and take your company’s mission to the next level.
ow.ly/n1aJ50IyHUf
#DrugDiscovery @proventaintl
Proventa International retweeted
@Biorasi is a proud sponsor of the @proventaintl Clinical Operations Strategy Meeting - East Coast USA 2022. Our own Jimmy El Hokayem, Ph.D. will be presenting on #COVID19 Related CNS Syndromes in Neurology #ClinicalTrials. Contact us today >> https://teapawt.net/t.co/W5RQz2TkEk
Proventa International retweeted
#cytokines were among the first immune treatments to be innovated. We talk to Randi Isaacs from @werewolfthera about their resurgence, improvements that in their specificity and the bright future of the technology in #oncology
pharmafeatures.com/interview…
#drugdesign
Proventa International retweeted
Thrilled to announce that Lance Hill, CEO, will be giving an afternoon keynote presentation at the @ProventaIntl annual Clinical Operations Strategy Meeting on May 18th! See you there?
Proventa International retweeted
#ctDNA not only promises quick #cancerdiagnostics, prognostics - but also improved treatment response monitoring, prediction and management - particularly for #immunotherapy
pharmafeatures.com/the-role-…
#oncology #oncologyresearch #immunooncology #nextgenerationsequencing
Proventa International retweeted
#COVID renews interest in #antiviral therapy as a treatment option; we explore a brief overview of antiviral therapy so far.
pharmafeatures.com/antiviral…
Proventa International retweeted
Over 60 peptide drugs have been FDA-approved, and over 150 peptides are in active development today. Oncology and neurology are two therapeutic areas in particular, which are benefiting from peptide drug discovery.
https://teapawt.net/t.co/9SdI2NrD4u
Proventa International retweeted
Recent advancements in oncology, specifically the weighing of cancer cells, has potential to support precision treatment for a multitude of patients and cancer types.
https://teapawt.net/t.co/EqVD5cSGh2
Proventa International retweeted
This week in pharmaceutical investments, Parse Biosciences partners with Decode Science to expand distribution capacity; Bionano completes $100m acquisition of BioDiscovery; Supernus continues to invest in CNS portfolio, with $40m buyout of Adamas.
https://teapawt.net/t.co/FjO3saXvz3
Proventa International retweeted
To fully understand and combat the Covid-19 threat, computational models have been developed to study the transmission of the SARS-CoV-2 virus, in order to address current challenges and provide more data to predict potential future threats.
https://teapawt.net/t.co/UGKqGXz8su
Proventa International retweeted
By 2028, the hydrogel-based drug delivery system market is estimated to be worth $10.29bn. With advantages of localised drug toxicity and great biocompatibility, the market of hydrogel-based drug delivery systems continues to grow at rapid rate.
https://teapawt.net/t.co/pnJYoQUSsp
Proventa International retweeted
From aggressive cancer types, to high relapse rates – many patients fail to access effective treatment. The latest innovations in CAR-T therapy methods demonstrate the importance of precision treatment, and offer hope for refractory patients.
https://teapawt.net/t.co/YlxADBijlx
Proventa International retweeted
GPCR-targeted drug discovery has demonstrated the potential for exciting therapeutic innovations across areas like oncology, utilising biotechnological advancements such as nanobody tethering.
https://teapawt.net/t.co/TVCYoSfjjt
Proventa International retweeted
The growing importance of #chirality in 3D chemical space exploration demonstrates a shift in modern #drugdiscovery for hit-to-lead identification.
https://teapawt.net/t.co/eH44sEtaJ7
Proventa International retweeted
Some of the biggest pharmaceutical leaders are focusing on the integration of computational modelling within their drug development process. In silico models are becoming increasingly popular not only in drug discovery, but across clinical research.
https://teapawt.net/t.co/uzqJ5z6k0w
Proventa International retweeted
Investigating discussions on social media about clinical experiences, and drug-related side effects are a few ways in which pharma companies are creating a more patient-centric drug development process, using a technique known as #socialmediamining.
https://teapawt.net/t.co/TTKRyIOXqe
Proventa International retweeted
In 2020, it was reported at least 115,000 people were living with #Crohnsdisease in the UK. Currently, there is no cure for CD. R&D in this area is ongoing, with recent innovations stem cell therapy demonstrating exciting clinical trial results.
https://teapawt.net/t.co/SKRmxGdTW7
Proventa International retweeted
This week in pharma investments, Boehringer seals the deal to expand its #immunooncology portfolio with the acquisition of biotech company Abexxa; #Novartis acquires Arctos Medical in a bid to support the expansion of its gene therapy pipeline.
https://teapawt.net/t.co/mrk8IHm75G
Proventa International retweeted
Synthetic DNA represents an innovative approach to drug discovery, with the potential to revolutionise areas like antibody therapeutics and cancer treatment.
https://teapawt.net/t.co/QOfyK88Uou
Proventa International retweeted
In recent news, #AstraZeneca seeks expansion in API manufacturing with a $360 million investment in a Dublin facility; the pharma industry faces increasing pressure to develop more sustainable manufacturing processes.
https://teapawt.net/t.co/rFKBhPToDO








